View drug registration information details.
Items | Registration information |
ID | 136 |
No | 136 |
Brand Name | ESOPRAZOLE-20 |
Ingredients | ESOMEPRAZOLE MAGNESIUM EQ.TO ESOMEPRAZOLE USP 20 MG |
Dosage Form | CAPSULE |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 36 MONTHS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | PPI |
Indications | GASTRO-OESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX OESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED OESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE, HEALING OF GASTRIC ULCERS ASSOCIATED WITH NSAID THERAPY, PREVENTION OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NSAID THERAPY IN PATIENTS AT RISK, HEALING OF HELICOBACTER PYLORI ASSOCIATED DUODENAL ULCER |
Contraindications | HYPERSENSITIVITY TO ESOMEPRAZOLE, OR TO ANY EXCIPIENT FROM FORMULATION, NOT BE USED CONCOMITANTLY WITH NELFINAVIR |
Side Effects | HEADACHE, ABDOMINAL PAIN, DIARRHEA, NAUSEA |
Unit Price | |
EDL |
No |
Description | PINK COLORED CAP & CLEAR TRANSPARENT BODY OF CAPSULE SIZE 2, CONTAINING WHITE PELLETS |
Note | |
License Owner | ASA LAO SOLE COMPANY LIMITED |
Manufacturer | IMPULSE PHARMA PVT. LTD |
Country | INDIA |
Import Registration No | KD/641 (FORM 25) |
Import Registration Date | 2022-08-11 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-07-17 |
FDD Registration No | 04 I 5726/24 |
FDD Registration Date | 26/4/2024 |
Expiry Date | 25/4/2027 |
Back to drug list
|